Response to 'Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial'

被引：0
|
作者：
Krhut, J. [1 ]
Samal, V. [2 ]
Nemec, D. [1 ]
Zvara, P. [3 ]
机构：
[1] Univ Hosp, Dept Urol, Ostrava, Czech Republic
[2] Reg Hosp, Dept Urol, Liberec, Czech Republic
[3] Univ Vermont, Div Urol, Burlington, VT USA
来源：
SPINAL CORD | 2013年 / 51卷 / 09期
关键词：
D O I：
10.1038/sc.2013.63
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [21] Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study
    Peyronnet, Benoit
    Castel-Lacanal, Evelyne
    Roumiguie, Mathieu
    Even, Lucie
    Marque, Philippe
    Soulie, Michel
    Rischmann, Pascal
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (03) : 734 - 739
  • [22] Preoperative Urodynamic Factors Predicting Outcome of Botulinum Toxin-A Intradetrusor Injection in Children With Neurogenic Detrusor Overactivity
    Kim, Sang Woon
    Choi, Jae Hyeok
    Lee, Yong Seung
    Han, Sang Won
    Im, Young Jae
    UROLOGY, 2014, 84 (06) : 1480 - 1484
  • [23] Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: Urodynamic outcome and patient satisfaction
    Ghalayini, Ibrahim Fathi
    Al-Ghazo, Mohammed A.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (04) : 531 - 536
  • [24] Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Pro
    Denys, P.
    Joussain, C.
    PROGRES EN UROLOGIE, 2023, 33 (04): : 174 - 175
  • [25] Re: Failure of Botulinum Toxin Injection for Neurogenic Detrusor Overactivity: Switch of Toxin Versus Second Injection of the Same Toxin
    Irkilata, Lokman
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (04): : 204 - 204
  • [26] Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity
    Ciofu, Irina
    Ceausu, Iuliana
    Chirca, Narcis Marian
    Persu, Cristian
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (05) : E507 - E511
  • [27] Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Cons
    Del Popolo, G.
    Gemma, L.
    PROGRES EN UROLOGIE, 2023, 33 (04): : 176 - 177
  • [28] Onabotulinum Toxin A has a long-term effects on neurogenic Detrusor Overactivity Comment
    Pannek, Jurgen
    AKTUELLE UROLOGIE, 2017, 48 (02) : 103 - +
  • [29] Clinical and Urodynamic Results of Repeated Intradetrusor Onabotulinum Toxin A Injections in Refractory Neurogenic Detrusor Overactivity: Up to 5 Injections in a Cohort of Children With Myelodysplasia
    Sekerci, Cagri Akin
    Tanidir, Yiloren
    Garayev, Asgar
    Akbal, Cem
    Tarcan, Tufan
    Simsek, Ferruh
    UROLOGY, 2018, 111 : 168 - 175
  • [30] Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity
    Perrouin-Verbe, B.
    Ruffion, A.
    Game, X.
    Denys, P.
    Kerdraon, J.
    Karsenty, G.
    de Seze, M.
    Haab, F.
    Saussine, C.
    Soler, J. -M.
    Amarenco, G.
    Chartier-Kastler, E.
    PROGRES EN UROLOGIE, 2009, 19 (06): : 372 - 382
12345